Evonile Pharma Limited

Evonile Pharma Limited Board Approves ₹900 Crore Rights Issue for Fund Raising

Evonile Pharma Limited, formerly Novartis India, approves raising up to ₹900 crore via a rights issue of partly paid-up equity shares to eligible shareholders.

Novartis India · 8 Oct 2026, 7:03 PM IST